ArticlePloS one2026
Genetic and pharmacologic inhibition of calcineurin reduces biofilm formation by the pathogenic fungus Trichosporon asahii in an in vivo silkworm infection model.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Trichosporon asahii is a dimorphic pathogenic fungus that causes catheter-related bloodstream infection in immunocompromised patients with neutropenia. Biofilm formation by T. asahii on the surfaces of medical devices such as catheters is influenced by various host environmental factors. Calcineurin, a protein phosphatase composed of the catalytic subunit Cna1 and the regulatory subunit Cnb1, regulates multiple stress responses and virulence of T. asahii. The role of calcineurin in biofilm formation under host-derived conditions, however, remains unclear. Here, we demonstrated that calcineurin is essential for biofilm formation in vivo by T. asahii. While the cna1 gene- and the cnb1 gene-deficient mutants formed biofilms comparable to those of the parent strain in vitro, it produced significantly less biofilm than the parent strain in the in vivo silkworm infection model. Similarly, tacrolimus, a calcineurin inhibitor, did not inhibit biofilm formation by T. asahii in vitro but markedly suppressed biofilm formation in vivo. Together, these findings suggest that calcineurin plays a crucial role in biofilm formation by T. asahii under host environmental conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.